{"entity":{"id":"brandon-wainwright","kind":"person","name":"Brandon Wainwright","aka":[],"tldr":"Geneticist known for work on the genetic drivers of childhood brain cancer who became Director and CEO of QIMR Berghofer, a leading Australian medical research institute, in 2026.","summary":"Professor Brandon Wainwright AM is Director and CEO of QIMR Berghofer Medical Research Institute in Brisbane, an Australian medical research institute with major cancer research programmes, a role he took up in 2026. He was previously Professor at The University of Queensland, led its Institute for Molecular Bioscience until 2019 and was Co-Director of the Children's Brain Cancer Centre. His research addresses genetic pathways in medulloblastoma and other cancers, including the role of Hedgehog signalling.","asOf":"2026-09-10","links":[{"label":"Source: QIMR Berghofer directors page","url":"https://www.qimrb.edu.au/about/governance/directors"}],"tags":["leadership","clinician-scientist","genetics","paediatric-oncology"],"related":[],"cancers":["medulloblastoma"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["qimr-berghofer"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Director and CEO of QIMR Berghofer Medical Research Institute","institutionId":"qimr-berghofer","specialisms":["Cancer genetics","Medulloblastoma","Hedgehog signalling","Research leadership"],"profiles":[{"label":"QIMR Berghofer directors page","url":"https://www.qimrb.edu.au/about/governance/directors"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Wainwright+BJ%5BAuthor%5D"}],"papers":[{"title":"Familial melanoma and p16 — a hung jury","journal":"Nature Genetics","year":1994,"doi":"10.1038/ng0994-3"},{"title":"Efficient detection and monitoring of pediatric brain malignancies with liquid biopsy based on patient-specific somatic mutation screening","journal":"Neuro-Oncology","year":2023,"doi":"10.1093/neuonc/noad032"},{"title":"Hedgehog pathway inhibitor saridegib (IPI-926) increases lifespan in a mouse medulloblastoma model","journal":"Proceedings of the National Academy of Sciences","year":2012,"doi":"10.1073/pnas.1114718109"}]},"route":"/people/brandon-wainwright/","neighbours":{"cancer":[{"id":"medulloblastoma","kind":"cancer","name":"Medulloblastoma","route":"/cancers/medulloblastoma/"}],"institution":[{"id":"qimr-berghofer","kind":"institution","name":"QIMR Berghofer Medical Research Institute","route":"/institutions/qimr-berghofer/"}]}}